
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title |
Status![]() |
---|---|---|---|---|---|---|---|
2021 | R21 | CA256081 | RFA-CA-20-017 | SWAGER, TIMOTHY M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation | Active |
2020 | R33 | CA246363 | RFA-CA-19-020 | LEVINSON, NICHOLAS MARK | UNIVERSITY OF MINNESOTA | Time-resolved FRET-based allostery sensors for any protein kinase drug target | Active |
2019 | R21 | CA235340 | RFA-CA-18-002 | ZHU, YAZHEN | UNIVERSITY OF CALIFORNIA LOS ANGELES | Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs | Active |
2018 | R21 | CA223715 | RFA-CA-17-010 | SHI, TUJIN | BATTELLE PACIFIC NORTHWEST LABORATORIES | An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cells | Active |
2021 | R21 | CA256082 | RFA-CA-20-017 | BAR-PELED, LIRON | MASSACHUSETTS GENERAL HOSPITAL | Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors | Active |
2020 | R33 | CA246455 | RFA-CA-19-020 | CHEN, FEI | BROAD INSTITUTE, INC. | Clinical implementations of spatial transcriptomics in tumors | Active |
2019 | R21 | CA236561 | RFA-CA-18-002 | WEISSLEDER, RALPH | MASSACHUSETTS GENERAL HOSPITAL | Single Circulating Vesicle Analysis for Early Cancer Detection | Active |
2022 | R33 | CA267221 | CA21-004 | NORMAN, THOMAS MAXWELL | SLOAN-KETTERING INST CAN RESEARCH | Systematic characterization of cancer variants using single-cell functional genomics | Active |
2021 | R21 | CA258019 | RFA-CA-20-017 | CHEN, KAI | UNIVERSITY OF SOUTHERN CALIFORNIA | Novel Bisphosphonate PET Probes for Myeloma Bone Disease | Active |
2020 | R33 | CA246711 | RFA-CA-19-020 | FAN, RONG | YALE UNIVERSITY | High-throughput single-cell co-sequencing of small and large RNAs to identify molecular circuitry in cancer | Active |
2019 | R21 | CA236594 | RFA-CA-18-002 | GARBER, MANUEL | UNIV OF MASSACHUSETTS MED SCH WORCESTER | A modular; customizable sequencing system for simultaneous genotyping and transcript analysis in single cells | Active |
2021 | R33 | CA247700 | RFA-CA-20-018 | JI, HANLEE P | STANFORD UNIVERSITY | Multimodal iterative sequencing of cancer genomes and single tumor cells | Active |
2020 | R21 | CA246359 | RFA-CA-19-021 | SEIBEL, ERIC J | UNIVERSITY OF WASHINGTON | Rapid Needle Biopsy Assessment at Point of Care to advance personalized cancer therapy | Active |
2019 | R21 | CA236640 | RFA-CA-18-002 | BHATNAGAR, PARIJAT | SRI INTERNATIONAL | T-cell Biofactories for targeting interstitial fluid pressure | Active |
2018 | R33 | CA223947 | RFA-CA-17-011 | BROWN, BRIAN D | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Pro-Codes: A novel vector and cell barcoding technology | Active |
2021 | R33 | CA247744 | RFA-CA-20-018 | GARTNER, ZEV JORDAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | Universal Sample Multiplexing for Single Cell Analysis | Active |
2020 | R33 | CA247669 | RFA-CA-19-022 | HASHAM, MUNEER GULAMHUSEIN | JACKSON LABORATORY | Impact of Genetic Diversity on Human Xenograft Tumor Growth | Active |
2019 | R21 | CA236685 | RFA-CA-18-002 | MANALIS, SCOTT R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Building microenvironment-containing organoids from patient samples with single-cell precision | Active |
2018 | R33 | CA223581 | RFA-CA-17-011 | CHENG, JI-XIN | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) | Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level | Active |
2021 | R33 | CA251006 | RFA-CA-20-020 | HAUN, JERED BRACKSTON | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic tumor tissue processing platform for single cell diagnostics | Active |
2020 | R43 | CA243757 | PAR-18-303 | ERVIN, ERIC | ELECTRONIC BIOSCIENCES, INC. | N6-Methyl-2-O-Methyladenosine Sequencing | Active |
2019 | R21 | CA236690 | RFA-CA-18-002 | KIM, HYUN JUNG | UNIVERSITY OF TEXAS, AUSTIN | A personalized colorectal cancer-on-a-chip for assessing tumor-microbiome crosstalk | Active |
2019 | R21 | CA240148 | RFA-CA-18-002 | ANGEL, PEGGY M | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Enzymatic Tools for 2D Tissue Localized and Deeper Proteomic Sequencing of Cancer Stromal Proteins | Active |
2021 | R33 | CA255893 | RFA-CA-20-018 | SEELIG, GEORG | UNIVERSITY OF WASHINGTON | Joint receptor and protein expression immunophenotyping through split-pool barcoding | Active |
2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Active |
2019 | R21 | CA240162 | RFA-CA-18-002 | KEUNG, ALBERT | NORTH CAROLINA STATE UNIVERSITY RALEIGH | Intracellular CRISPR gRNA assembly for massively multiplexed; one pot; (epi)genetic screening | Active |
2018 | R33 | CA225539 | RFA-CA-17-011 | JIANG, NING | UNIVERSITY OF TEXAS, AUSTIN | An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer | Active |
2022 | R21 | CA257816 | CA21-003 | COUNTER, CHRISTOPHER M | DUKE UNIVERSITY | Adapting K-MDS to detect KRAS-mutant ctDNA | Active |
2021 | R33 | CA256102 | RFA-CA-20-018 | GREENBERG, JOEL | DUKE UNIVERSITY | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | Active |
2020 | R43 | CA250805 | PAR-18-303 | WANG, SHA | VIVID TECHNOLOGIES | New specific and rapid assay for in situ apoptosis labeling for cancer studies | Active |
2019 | R21 | CA240199 | RFA-CA-18-002 | O'NEILL, RACHEL | UNIVERSITY OF CONNECTICUT STORRS | Development and Utilization of Splice-specific Antibodies | Active |
2022 | R33 | CA261696 | CA21-004 | MERAJVER, SOFIA DIANA | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence | Active |
2021 | R33 | CA257878 | RFA-CA-20-018 | HANSEN, ANDERS SEJR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer | Active |
2020 | R21 | CA240220 | RFA-CA-19-019 | ALEXANDRAKIS, GEORGIOS | UNIVERSITY OF TEXAS ARLINGTON | Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy | Active |
2019 | R21 | CA240580 | RFA-CA-18-002 | MONTAGNA, CRISTINA | ALBERT EINSTEIN COLLEGE OF MEDICINE | Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions | Active |
2022 | R33 | CA269015 | CA21-004 | ADEY, ANDREW | OREGON HEALTH & SCIENCE UNIVERSITY | Accessible high-throughput single-cell genome sequencing | Active |
2021 | R33 | CA258016 | RFA-CA-20-018 | LIU, XUEFENG | OHIO STATE UNIVERSITY | Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics | Active |
2020 | R33 | CA247739 | RFA-CA-19-020 | MATRIX BHATNAGAR, PARIJAT | SRI INTERNATIONAL | T-cell Biofactories For Targeting Extracellular Matrix | Active |
2019 | R33 | CA225458 | RFA-CA-18-003 | KETTENBACH, ARMINJA NADINE | DARTMOUTH COLLEGE | Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics | Active |
2022 | R33 | CA258012 | CA21-004 | KARGINOV, ANDREI V | UNIVERSITY OF ILLINOIS AT CHICAGO | Optogenetic Control of Tumor Initiation and Tumor Progression in vivo | Active |
2021 | R44 | CA261523 | PAR-18-303 | HUNG, PAUL JU-SUNG | COMBINATI, INC. | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring | Active |
2020 | R33 | CA240181 | RFA-CA-19-020 | COOKS, ROBERT GRAHAM | PURDUE UNIVERSITY | Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies | Active |
2019 | R33 | CA225498 | RFA-CA-18-003 | CHEN, SIDI | YALE UNIVERSITY | Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers | Active |
2022 | R21 | CA269091 | CA21-005 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions | Active |
2020 | R21 | CA251042 | RFA-CA-19-021 | GUPTA, GAUTAM | UNIVERSITY OF LOUISVILLE | Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens | Active |
2019 | R33 | CA225549 | RFA-CA-18-003 | TAVANA, HOSSEIN | UNIVERSITY OF AKRON | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | Active |
2018 | R33 | CA228979 | RFA-CA-17-011 | SCHRUM, ADAM G | UNIVERSITY OF MISSOURI-COLUMBIA | Multiplex matrix ELISA for T cell protein-interaction networks in cancer | Active |
2022 | R33 | CA269094 | CA21-004 | MOELLERING, RAYMOND E | UNIVERSITY OF CHICAGO | Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues | Active |
2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Active |
2019 | R33 | CA229042 | RFA-CA-18-003 | SCHNECK, JONATHAN P | JOHNS HOPKINS UNIVERSITY | A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells | Active |